Freestone Grove Partners LP Innoviva, Inc. Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
A detailed history of Freestone Grove Partners LP transactions in Innoviva, Inc. stock. As of the latest transaction made, Freestone Grove Partners LP holds 38,825 shares of INVA stock, worth $700,014. This represents 0.01% of its overall portfolio holdings.
Number of Shares
38,825Holding current value
$700,014% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding INVA
# of Institutions
243Shares Held
77.7MCall Options Held
52.8KPut Options Held
800-
Black Rock Inc. New York, NY9.63MShares$174 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$131 Million39.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$114 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$113 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.92MShares$88.7 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.26B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...